1.19637
LiChrospher® 100 RP-18 endcapped (5 µm) HPLC Columns
HPLC sorbent
別名:
TM=["LiChrospher"] C18 sorbent for HPLC
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
UNSPSC Code:
41115709
NACRES:
SB.52
Particle size:
5 μm
Matrix active group:
C18 (RP18), C18 bonding phase
Pore size:
100 Å pore size
Matrix:
fully porous particle
製品名
LiChrospher® 100 RP-18 endcapped (5 µm),
material
stainless steel column
agency
suitable for USP L1
product line
LiChrospher®
feature
endcapped
packaging
1 ea of
extent of labeling
21.6% Carbon loading
parameter
60 °C max. temp.
technique(s)
HPLC: suitable, mass spectrometry (MS): suitable (Low - Medium)
surface area
350 m2/g
matrix
fully porous particle
matrix active group
C18 (RP18), C18 bonding phase
particle size
5 μm
pore size
100 Å pore size
operating pH range
2-7.5
bulk density
200‑400 kg/m3
separation technique
reversed phase
storage temp.
no temp limit
General description
LiChrospher® RP-18 endcapped is a reliable and versatile traditionally produced spherical silica gel carrier with revered phase properties. It is well suited for the separation of neutral, acidic and weak basic compounds.
Application
- Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD: The robustness of the LiChrospher® 60 RP-select B column is highlighted in forensic science, where it is used to accurately identify and quantify cannabinoids, demonstrating its critical role in legal and forensic analyses (Ambach et al., 2014).
- RP-HPLC separation and characterization of unknown impurities of a novel HIV-protease inhibitor Darunavir by ESI-MS and 2D NMR spectroscopy: The LiChrospher® 60 RP-select B column′s exceptional selectivity and performance are utilized to identify novel impurities in Darunavir, highlighting its application in developing more effective HIV treatments (Nageswara Rao et al., 2013).
- Quantification of pralidoxime (2-PAM) in urine by ion pair chromatography-diode array detection: Demonstrating versatility, this column was used to detect therapeutic agents in clinical settings, supporting treatment regimes for poisonings where rapid and accurate drug monitoring is essential (John et al., 2012).
Analysis Note
Application test: passes test
Pressure: ≤ 50 bar
Theoretical Plates (N/m) (Toluene): ≥ 60000
stability testing (performance): passes test
Particle Size (d10): 4.8 - 5.5 µm
Particle Size (d50): 6.5 - 7.5 µm
Particle Size (d90): 9.0 - 10.5 µm
Pressure: ≤ 50 bar
Theoretical Plates (N/m) (Toluene): ≥ 60000
stability testing (performance): passes test
Particle Size (d10): 4.8 - 5.5 µm
Particle Size (d50): 6.5 - 7.5 µm
Particle Size (d90): 9.0 - 10.5 µm
Legal Information
LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under LiChrospher® 100 RP-18 endcapped (5 µm)
保管分類
11 - Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。